ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

KRSA vs OMER // ENTERPRISE SCALE & MARKET CAP

Korsana Biosciences Inc. (NASDAQ) VS. Omeros Corporation (NASDAQ) • 15-METRIC TALLY: KRSA 4 — OMER 1
▲ ENTERPRISE SCALE & MARKET CAP LEADER: KRSA
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KRSA VS. OMER) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC KRSA OMER SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -5.70% -35.00% +29.30 KRSA /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -0.24% -8.47% +8.23 KRSA /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) 3.70% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 1/9 +1.00 KRSA /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 45.6 53.6 -7.95 OMER /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $1.38B $1.37B $4.5M KRSA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR KRSA REV OMER REV KRSA GROSS % OMER GROSS % KRSA FCF OMER FCF
FY 2025 $2.1M $0 — — -$3.3M -$116.2M
FY 2024 $2.0M $0 — — -$4.3M -$149.0M
FY 2023 $0 — — — -$21.2M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KRSA // BETA —
OMER // BETA —